Sangamo Therapeutics Inc
Research Sangamo Therapeutics Inc (SGMO) on Bullrun: market cap USD 30.66M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSGMO
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 30.66M
- Financial periodQ1 2026
- RevenueUSD 1.44M
- Net income-USD 123.33M
- Free cash flow-USD 90.46M
Valuation Snapshot
latest market cap is USD 30.66M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 39.55M | -USD 122.93M | -USD 97.31M | n/a | -0.44 | USD 20.95M | USD 26.80M | -USD 14.27M |
| FY2024 | USD 57.80M | -USD 97.94M | -USD 67.41M | n/a | -0.49 | USD 41.92M | USD 30.57M | USD 22.77M |
| FY2023 | USD 176.23M | -USD 257.83M | -USD 246.00M | n/a | -1.48 | USD 45.20M | USD 38.10M | USD 82.89M |
| FY2022 | USD 111.30M | -USD 192.28M | -USD 243.80M | n/a | -1.25 | USD 100.44M | USD 41.53M | USD 294.96M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-07-02 | USD 30.66M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 147.29M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 217.09M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 95.77M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 514.58M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 1.09B | n/a | n/a | n/a |
About Sangamo Therapeutics Inc
Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States. The company's clinical-stage product candidates are ST-920, a gene therapy product candidate, which is in Phase 1/2 clinical study for the treatment of Fabry disease; small fiber neuropathy for chronic neuropathic pain, and prion disease;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Sangamo Therapeutics Inc's market cap?
Sangamo Therapeutics Inc's market capitalization is USD 30.66M.
What does Sangamo Therapeutics Inc do?
Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.